Xiaoyan Qiu
- Transplantation top 10%
- Clinical Biochemistry top 10%
-
- Glycosylation and Glycoproteins Research 5
-
- Protease and Inhibitor Mechanisms 2
-
- Galectins and Cancer Biology 3
-
- Pancreatic and Hepatic Oncology Research 3
- Chemokine receptors and signaling 3
-
- SARS-CoV-2 and COVID-19 Research 2
-
- Endometriosis Research and Treatment 2
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Dalong MaQian LiPengfei LiKuang‐Hueih ChenDongmei YangRui‐Ping XiaoXiaomei GuoYanhong Guo
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Xiaoyan Qiu
26 papers receiving 611 citations
Peers
Comparison fields: 5 of 74
- Transplantation 27
- Clinical Biochemistry 61
- Molecular Biology 399
- Cancer Research 85
- Immunology 109
Countries citing papers authored by Xiaoyan Qiu
This map shows the geographic impact of Xiaoyan Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyan Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyan Qiu more than expected).
Fields of papers citing papers by Xiaoyan Qiu
This network shows the impact of papers produced by Xiaoyan Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyan Qiu. The network helps show where Xiaoyan Qiu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaoyan Qiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 17 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 2 | |
| 8 | 2021 | 1 | |
| 9 | 2021 | 10 | |
| 10 | 2020 | 23 | |
| 11 | 2019 | 28 | |
| 12 | 2017 | 1 | |
| 13 | 2014 | 18 | |
| 14 | 2011 | 5 | |
| 15 | 2011 | 38 | |
| 16 | 2010 | 21 | |
| 17 | 2009 | 5 | |
| 18 | 2007 | 9 | |
| 19 | 2006 | 45 | |
| 20 | 2003 | 3 |
About Xiaoyan Qiu
Xiaoyan Qiu is a scholar working on Oncology, Immunology and Transplantation, having authored 26 papers that have together received 618 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (5 papers), Pancreatic and Hepatic Oncology Research (3 papers), Chemokine receptors and signaling (3 papers), Galectins and Cancer Biology (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Protease and Inhibitor Mechanisms (2 papers), Endometriosis Research and Treatment (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Transplantation (27 citations), Clinical Biochemistry (61 citations) and Molecular Biology (399 citations). Xiaoyan Qiu has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Dalong Ma, Qian Li, Pengfei Li, Kuang‐Hueih Chen, Dongmei Yang, Rui‐Ping Xiao, Xiaomei Guo, Yanhong Guo, Shaojun Wen and Jian Tang. Their work appears in journals such as Acta Pharmacologica Sinica, Fertility and Sterility, Neoplasia, BMB Reports and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.